Companies
Healthpeak Properties Inc
NYSE: DOC
$19.84
▼ $0.14 (−0.70%) today
Markets open · 2:17pm ET

Healthpeak Properties (DOC) Q3 2026 Earnings

Reported Nov 2, 2026, 4:10pm ET · SEC source
$0.44
Miss +0.00%
EPS · est. $0.00 Adjusted

FFO as Adjusted excludes $8.379 million of transaction, merger, and restructuring-related costs (including senior housing operator transition costs); GAAP diluted EPS was $0.02

$820.9M
Miss +0.00%
Revenue · est. $0
3 quarters
Consecutive EPS beats

How Did DOC Stock React to Q3 2026 Earnings?

+2.36%
Day of report
+0.41%
Next session
+5.85%
One week

Did DOC Beat Earnings? Q3 2026 Results

Healthpeak Properties delivered a mixed but strategically eventful third quarter of 2026, with adjusted FFO per share of $0.44 on revenue of $820.89 million, as robust senior housing momentum offset softness in its lab segment. The standout driver was Janus Living, Healthpeak's majority-owned senior housing REIT, which posted revenue of $268.00 million, up 78% year over year, and Adjusted EBITDAre of $105.00 million, up 101%, fueled by $1.75 billion in acquisitions closed during the quarter. Same-store senior housing NOI surged 25.9%, while the lab segment slipped 0.7% and outpatient medical grew a steady 3.1%. On a GAAP basis, Healthpeak swung to a profit of $0.02 per diluted share from a loss of $0.17 a year ago, when results were weighed down by $175.83 million in impairment charges on lab joint ventures. Looking ahead, management raised its full-year FFO as Adjusted guidance to $1.76 to $1.78 per share while trimming its GAAP EPS outlook to $0.39 to $0.41, attributing the latter reduction to depreciation tied to Janus Living's acquisition activity.

Key Takeaways
  • Total Same-Store Adjusted NOI growth of 3.6% year over year
  • Senior Housing same-store Adjusted NOI up 25.9%; Outpatient Medical up 3.1%; Lab down 0.7%
  • Janus Living revenue up 78% to $268 million and Adjusted EBITDAre up 101% to $105 million
  • Outpatient Medical leasing of 846,000 sq ft in Q3 (3.2 million sq ft YTD)
  • Lab leasing of 480,000 sq ft in Q3 (1 million sq ft YTD); Lab occupancy up 130 bps sequentially and 270 bps since year-end 2025
  • $1.75 billion of senior housing acquisitions closed by Janus Living during Q3

What Is Healthpeak Properties's Outlook?

Healthpeak raised its full-year 2026 diluted FFO as Adjusted guidance to $1.76–$1.78 per share (from $1.73–$1.77), a $0.02 midpoint increase. It raised Total Same-Store Cash (Adjusted) NOI growth guidance to 0.5%–2.0% (from 0%–1.5%). It lowered diluted EPS guidance to $0.39–$0.41 (from $0.48–$0.52), primarily due to depreciation and amortization from Janus Living's senior housing acquisitions, which has no impact on FFO as Adjusted. Diluted Nareit FFO is guided at $1.72–$1.74. Two pending life science acquisitions are expected to close in Q4 2026 or early 2027.

DOC YoY Financials

Revenue$820.9M
Net Income$17.3M

DOC Revenue by Segment

Outpatient Medical$314.8M−3.6%
Senior Housing$268.3M
Lab$223.9M+4.9%
Life Plan
CCRC

When Does Healthpeak Properties Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.